Prostate Tumorigenesis Induced by PTEN Deletion Involves Estrogen Receptor β Repression
Open Access
- 1 March 2015
- journal article
- Published by Elsevier in Cell Reports
- Vol. 10 (12) , 1982-1991
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- A phosphotyrosine switch determines the antitumor activity of ERβJournal of Clinical Investigation, 2014
- The Role of Estrogen Receptor β in Prostate CancerMolecular Medicine, 2014
- Insight into the mechanisms of action of estrogen receptor β in the breast, prostate, colon, and CNSJournal of Molecular Endocrinology, 2013
- JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostateProceedings of the National Academy of Sciences, 2012
- Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancerJournal of Clinical Investigation, 2012
- The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cellsJournal of Clinical Investigation, 2009
- Thymocyte Proliferation Induced by Pre-T Cell Receptor Signaling Is Maintained through Polycomb Gene Product Bmi-1-Mediated Cdkn2a RepressionImmunity, 2008
- Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancerCancer Cell, 2003
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- FUNCTIONAL EXPRESSION OF SV40 IN NORMAL HUMAN PROSTATIC EPITHELIAL AND FIBROBLASTIC CELLS - DIFFERENTIATION PATTERN OF NONTUMORIGENIC CELL-LINESInternational Journal of Oncology, 1995